Humasis Co. Ltd. (KOSDAQ:205470)
South Korea · Delayed Price · Currency is KRW 1,000.00
-36.00 (-3.47%)
Jan 30, 2026, 3:30 PM KST
Humasis Market Cap
Humasis has a market cap or net worth of 113.15 billion as of January 30, 2026. Its market cap has decreased by -41.25% in one year.
Market Cap
113.15B
Enterprise Value
-40.52B
Revenue
35.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,000.00
Market Cap Chart
Since September 27, 2017, Humasis's market cap has increased from 10.76B to 113.15B, an increase of 951.30%. That is a compound annual growth rate of 32.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 113.15B | -1.38% |
| Dec 30, 2025 | 114.74B | -38.06% |
| Dec 30, 2024 | 185.23B | -22.80% |
| Dec 28, 2023 | 239.92B | -47.44% |
| Dec 29, 2022 | 456.45B | -20.07% |
| Dec 30, 2021 | 571.04B | 75.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.21T |
| Celltrion | 46.93T |
| ALTEOGEN | 23.00T |
| ABL Bio | 13.53T |
| Shinhung | 128.44B |
| Jeil Pharma Holdings | 123.27B |
| iNtRON Biotechnology | 123.23B |
| CKD Bio | 120.42B |